Wolverine Trading, LLC Gemini Therapeutics, Inc. Call Options Transaction History

Wolverine Trading, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$1.31 - $2.01 $20,043 - $30,752	15,300 New	15,300 $23,000
Q1 2022 May 16, 2022	SELL	$1.29 - $3.08 $16,899 - $40,348	-13,100 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.39 - $4.0 $7,170 - $12,000	-3,000 Reduced 18.63%	13,100 $40,000
Q3 2021 Nov 12, 2021	SELL	$3.3 - $6.32 $4,290 - $8,216	-1,300 Reduced 7.47%	16,100 $67,000
Q2 2021 Aug 06, 2021	BUY	$6.32 - $14.02 $109,968 - $243,948	17,400 New	17,400 $110,000

2.44M

Ticker GMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,244,500
Market Cap $1.05B
Description
Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD). Its lead candidate is GEM103, a recombinant form of the human complement factor H protein to treat dry AMD patients. The company also develops GEM307 ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.